Close
  Indian J Med Microbiol
 

Figure 3: Expression of interleukin-17 and interleukin-6 after treating with diosgenin detected by enzyme-linked immunosorbent assay. (a) Interleukin-17; (b) Interleukin-6. *P < 0.05 and **P < 0.01 versus control group,#P < 0.05 and##P < 0.01 versus collagen-induced arthritis model group;&P < 0.05 and&&P < 0.01 versus low-dose group; ΔΔP < 0.01 versus medium-dose group

Figure 3: Expression of interleukin-17 and interleukin-6 after treating with diosgenin detected by enzyme-linked immunosorbent assay. (a) Interleukin-17; (b) Interleukin-6. *<i>P</i> < 0.05 and **<i>P</i> < 0.01 versus control group,<sup>#</sup><i>P</i> < 0.05 and<sup>##</sup><i>P</i> < 0.01 versus collagen-induced arthritis model group;<sup>&</sup><i>P</i> < 0.05 and<sup>&&</sup><i>P</i> < 0.01 versus low-dose group; ΔΔ<i>P</i> < 0.01 versus medium-dose group